Related Experiment Videos

Interruption of growth signal transduction by an antiviral and antitumoral xanthate compound

K Müller-Decker1, C Doppler, E Amtmann

  • 1Institute for Virus Research, German Cancer Research Center, Heidelberg.

Insights

Tricyclodecane-9-yl-xanthogenate (D609) selectively inhibits protein kinase C (pkC) activation by epidermal growth factor (EGF) receptors. This preserves EGF receptor tyrosine autophosphorylation and prevents EGF-induced receptor downregulation and internalization.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Biochemistry

Background:

  • Growth factors bind cellular receptors, triggering protein phosphorylation and signal transmission to the nucleus.
  • Epidermal growth factor (EGF) binding activates both receptor tyrosine kinases and protein kinase C (pkC).

Purpose of the Study:

  • To investigate the selective inhibition of pkC activation by tricyclodecane-9-yl-xanthogenate (D609).
  • To determine the effect of D609 on EGF receptor tyrosine autophosphorylation, affinity, and internalization.

Main Methods:

  • Utilized tricyclodecane-9-yl-xanthogenate (D609) to selectively inhibit pkC activation.
  • Monitored receptor tyrosine autophosphorylation in the presence of D609.
  • Assessed EGF receptor affinity and internalization following D609 treatment.

Main Results:

  • D609 selectively inhibited pkC activation without affecting receptor tyrosine autophosphorylation.
  • EGF receptor affinity remained undiminished.
  • EGF-receptor complex internalization was prevented.

Conclusions:

  • D609 is a selective inhibitor of pkC activation in EGF signaling.
  • Inhibition of pkC prevents EGF receptor downregulation and internalization, decoupling it from initial receptor tyrosine kinase activity.

Related Concept Videos